This site is intended for health professionals only

Editor’s pick

Letrozole “cuts risk of breast cancer return”
Letrozole “cuts risk of breast cancer return”
Call for black-box warnings on ESAs
Call for black-box warnings on ESAs
EMEA optimistic after record year
EMEA optimistic after record year
Celgene closes $2.9bn Pharmion deal
Celgene closes $2.9bn Pharmion deal
Hypertension jab news gets pulses racing
Hypertension jab news gets pulses racing
Pharma “shooting itself in the foot” over reputation
Pharma “shooting itself in the foot” over reputation
Drug firm denies monopoly claims
Drug firm denies monopoly claims
Early data released from Phase IIIb Cimzia trial
Early data released from Phase IIIb Cimzia trial
Rapydan gains European approval
Rapydan gains European approval
Cell Therapeutics submits European MMA for Xyotax
Cell Therapeutics submits European MMA for Xyotax
German company develops alternative to stem cell therapy
German company develops alternative to stem cell therapy
Call for C difficile deaths probe
Call for C difficile deaths probe
1 … 211 212 213 214 215 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x